BILLS-109hr5887ih.pdf

23:53 Jul 26, 2006 5887 VerDate Aug 31 2005 quarterly the preceding 5 years July 1, 2006 later than 2 weeks fiscal year annually 2 years every 6 months 31 2005 25 2007 3 year 2007 8 year JULY 25, 2006 less than 7 years 90-day 1 year later than 18 months January 1, 2006

SESSION H. R. 5887

PO 00000 Frm PO 00000 Frm 00020 PO 00000 Frm 00012 PO 00000 Frm 00007 PO 00000 Frm 00016 PO 00000 Frm 00017 PO 00000 Frm 00019 PO 00000 Frm 00010 PO 00000 Frm 00023 Fmt PO 00000 Frm 00009 PO 00000 Frm 00021 Fmt PO 00000 Frm 00011 Fmt PO 00000 Frm 00022 PO 00000 Frm 00027 PO 00000 Frm 00015 PO 00000 Frm 00001 PO 00000 Frm 00018 PO 00000 Frm 00004 PO 00000 Frm 00024 Fmt PO 00000 Frm 00006 PO 00000 Frm 00008 Fmt PO 00000 Frm 00026 PO 00000 Frm 00025 Vac-

IH Florida States the United States the United States of America the United States Government

IH Vac-

HMBILLS Vaccine Safety Evaluation Agency SEC Disease Control and Prevention the Centers for Disease Control Safety Evaluation cine Safety Evaluation Congress CDC State Centers cine Safety Datalink Project Health and Human Services the Public Health Service Act Food and Drugs the National Institutes of Health the Food and Drug Administration Commission the Centers for Disease Control 4 THE HOUSE OF REPRESENTATIVES U.S.C. ADVISORY COUNCIL Safety Datalink Project Health FDA the Department of 21 Defense United ployed Defense House of Representa- Institutes of Health Drugs the Federal Government the Food and Drug Adminis- the National Immunization Program the Commissioner of Food and Drugs tional Library of Medicine the National Vaccine Program Office the National Institutes of 2145 RESPONSIBILITIES.—In Federal, State the National Vaccine Advisory the Health Resources and Services Administration the Department of 21 Health and Human Services the Department of Health and Human Services

WELDON MALONEY ister

vaccine vaccines adverse confidence mechanisms safety monitoring biological acute focus evaluation events chronic bills hmoore research